Medical review pending · noindex

Procedure comparison

HoLEP vs TURP: Enucleation or Resection?

HoLEP and TURP both remove obstructing prostate tissue through the urethra, but they do so differently. HoLEP uses a holmium laser to separate obstructing adenoma before tissue is removed from the bladder; TURP removes tissue in chips with an electrosurgical loop. Prostate volume, bleeding management, anesthesia, tissue handling, recovery, ejaculation and surgeon experience are central to the decision.

Decision-support boundary: This draft does not diagnose obstruction, select a procedure, or tell anyone to stop medication. Inability to urinate, fever with urinary symptoms, heavy bleeding, severe pain or rapidly worsening symptoms need prompt medical attention.

Direct answer

The better option is the one that fits measured anatomy and the outcomes you prioritize after contraindications, clinician experience, evidence limits and the complete recovery pathway are reviewed. Neither side of this comparison is universally superior.

Start by confirming why symptoms are occurring. Lower urinary tract symptoms can reflect prostatic obstruction, bladder dysfunction, infection, urethral narrowing, medicines, neurologic conditions or more than one factor. NIDDK notes that tests help clinicians diagnose urinary problems and determine treatment options. A procedure comparison becomes useful only after that diagnostic work is connected to the actual choice.

HoLEP vs TURP: decision matrix

Decision factorHoLEPTURP
Tissue approachEnucleates obstructing adenoma along an anatomical plane, followed by morcellation.Resects obstructing tissue in chips through a resectoscope.
Size and anatomyOften discussed across a broad size range, but suitability is individual.Technique and operative planning can vary with gland size and configuration.
Operator dependenceRequires specialized training and a functioning laser/morcellation program.Widely established, though outcomes still depend on technique and case selection.
Bleeding discussionLaser hemostasis is a reason it may enter the conversation; medication and bleeding history still require planning.Bleeding management differs by monopolar/bipolar technique, anatomy and health factors.
Sexual outcomesEjaculatory change is commonly discussed after tissue-removing surgery.Ejaculatory change is also a central consent topic; erection and ejaculation are separate outcomes.
Pathology and follow-upRemoved tissue is generally available for examination.Resected chips are generally available for examination.

This table describes decision dimensions, not a personalized recommendation. Device labeling, guideline language, techniques and local pathways can change; verify current details with the treating clinicians.

When the first pathway may enter the discussion

  • A more complete adenoma-removal approach fits the anatomy.
  • An experienced HoLEP surgeon and program are accessible.
  • Bleeding management or a larger gland makes enucleation worth discussing.

When the second pathway or another route may fit

  • TURP is well matched to the obstruction and available expertise.
  • You prefer a locally established resection pathway.
  • Your clinician considers the operative profile appropriate for your health and anatomy.

Do not compare unlike outcomes

Ask whether a study reports symptom score, peak urinary flow, quality of life, catheter independence, adverse events or repeat treatment. Those outcomes are related but not interchangeable. Also check the starting severity, prostate anatomy, exclusions, follow-up duration and how many participants supplied data at the reported time point. A five-year result from a selected trial population is not a guarantee for an individual.

For sexual outcomes, separate erection, ejaculation, orgasm, libido and fertility. A statement that erectile function was stable does not establish that antegrade ejaculation was preserved. For recovery, separate time to discharge, catheter removal, return to work, urinary irritation and full activity. Marketing phrases that collapse these outcomes can make a procedure appear more certain than the evidence supports.

Questions to take to the consultation

  1. How many HoLEP and TURP procedures do you perform?
  2. What does prostate imaging show about volume and configuration?
  3. How will blood-thinning medication be managed?
  4. What are your transfusion, readmission and retreatment rates?
  5. How long is catheterization typical in your program?
  6. How do you counsel on temporary leakage?
  7. What ejaculation outcome should I expect?
  8. How will removed tissue be examined and PSA followed?
Useful request: Ask the clinician to mark which facts are known from your testing, which are estimates from published evidence, and which depend on the center’s own protocol. Request written catheter, medication and after-hours instructions before scheduling.

Evidence and review status

This page uses authoritative patient guidance, a professional guideline and procedure-specific clinical evidence where available. It deliberately avoids unsourced prices, universal recovery times and promises of preserved sexual function. It remains excluded from the XML sitemap until a qualified medical reviewer checks every material claim, current device labeling and the final comparison language.

Sources accessed September 21, 2026. A source link does not mean the source endorses UriSmooth or this page.

Frequently asked questions

1. What should I know about tissue removal?

Tissue removal changes what remains after treatment and what information is available later. Ask whether HoLEP or TURP leaves an implant, supplies tissue for examination, or alters future imaging and procedural choices.

2. What should I know about large prostates?

Large prostates is one decision dimension, not a verdict for HoLEP or TURP. Ask the clinician to connect it to your documented obstruction, baseline symptoms, health history and the center’s technique, then identify what remains uncertain after current evidence is applied.

3. What should I know about bleeding?

Bleeding requires a coordinated plan, not self-directed medication changes. Ask the procedural clinician and prescribing clinician how HoLEP and TURP differ for your clotting risk, technique, monitoring and restart instructions.

4. What should I know about blood thinners?

Do not stop or change anticoagulant or antiplatelet medicine yourself. The prescriber and procedural team must coordinate a plan based on clotting and bleeding risks.

5. What should I know about catheter duration?

Catheter duration is part of the practical HoLEP versus TURP decision. Ask whether a catheter is planned, what triggers removal, where a voiding trial occurs and who responds if emptying fails. Your baseline residual urine and bladder function can matter more than a generic average.

6. What should I know about hospital stay?

Hospital stay depends on the exact pathway used for HoLEP or TURP. Request written instructions covering transport, discharge, urinary symptoms, activity limits, after-hours contact and the conditions that delay return to normal activity.

7. What should I know about temporary leakage?

Temporary leakage is one decision dimension, not a verdict for HoLEP or TURP. Ask the clinician to connect it to your documented obstruction, baseline symptoms, health history and the center’s technique, then identify what remains uncertain after current evidence is applied.

8. What should I know about ejaculation?

Ejaculation must be defined before comparing HoLEP with TURP. Ask what was measured at baseline, whether ejaculation and erection were reported separately, how many patients supplied follow-up, and why your medicines or health conditions may produce a different outcome.

9. What should I know about erections?

Erections must be defined before comparing HoLEP with TURP. Ask what was measured at baseline, whether ejaculation and erection were reported separately, how many patients supplied follow-up, and why your medicines or health conditions may produce a different outcome.

10. What should I know about pathology?

Pathology changes what remains after treatment and what information is available later. Ask whether HoLEP or TURP leaves an implant, supplies tissue for examination, or alters future imaging and procedural choices.

11. What should I know about retreatment?

Retreatment should be compared at the same follow-up interval with the same definition. For HoLEP and TURP, ask for the number treated, number assessed later, repeat-procedure criteria and the treating center’s own follow-up process.

12. What should I know about surgeon experience?

Surgeon experience can materially affect the real-world choice between HoLEP and TURP. Ask about training, recent case volume, complication tracking, rescue plans and whether another local center offers stronger expertise for your anatomy.

Next decision

Return to the BPH procedure decision hub, compare medication versus a procedure, or build a recovery and catheter plan. UriSmooth is not presented as a substitute for evaluation or a procedure.